These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7317235)

  • 1. Immediate and sustained haemodynamic effects of prazosin during upright exercise in man.
    Silke B; Hendry WG; Taylor SH
    Br Heart J; 1981 Dec; 46(6):663-70. PubMed ID: 7317235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
    Taylor SH; Silke B
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):45-51. PubMed ID: 6124209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure.
    Nelson GI; Donnelly GL; Hunyor SN
    J Cardiovasc Pharmacol; 1982; 4(2):240-5. PubMed ID: 6175807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
    Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of refractory congestive heart failure with prazosin.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasodilatation with captopril and prazosin in chronic heart failure: double blind study at rest and on exercise.
    Bayliss J; Canepa-Anson R; Norell MS; Poole-Wilson P; Sutton G
    Br Heart J; 1986 Mar; 55(3):265-73. PubMed ID: 3513808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Br Heart J; 1980 May; 43(5):550-5. PubMed ID: 7378215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved haemodynamics but reduced arterial blood oxygenation, at rest and during exercise after long-term oral prazosin therapy in chronic cor pulmonale.
    Vik-Mo H; Walde N; Jentoft H; Halvorsen FJ
    Eur Heart J; 1985 Dec; 6(12):1047-53. PubMed ID: 3938395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.
    von der Lippe G; Ohm OJ; Lund-Johansen P
    Acta Med Scand; 1981; 210(3):213-6. PubMed ID: 7293839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.